Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.91M 25.06M 23.49M 21.42M 40.3M 40.95M 277M 108M 1.38B 109M 106M 4.61B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.12M 26.11M 24.47M 22.32M 41.99M 42.66M 288M 113M 1.44B 113M 111M 4.8B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+2.08%
1 week+8.79%
Current month+4.37%
1 month+3.97%
3 months+9.33%
6 months+11.28%
Current year+1.65%
1 week 81
Extreme 81
89.5
1 month 76.95
Extreme 76.95
89.5
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 25.1
Extreme 25.1
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Compliance Officer 32 2023-04-18
Director TitleAgeSince
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%+8.79%+2.95%+237.46% 39.61M
-0.92%+1.43%+83.05%+128.86% 1,088B
+0.47%+1.98%+50.26%+50.75% 629B
+0.83%+2.85%+24.49%+64.82% 440B
-0.88%-0.66%+45.09%+36.64% 359B
-0.37%-1.15%+26.89%+36.31% 291B
+0.05%-1.20%+2.31%+6.15% 245B
+0.40%+3.21%+44.42%+59.17% 225B
-0.42%+1.58%-8.48%-51.94% 204B
+1.67%+5.56%+14.98%+72.68% 168B
Average +0.29%+2.13%+28.60%+64.09% 364.92B
Weighted average by Cap. -0.13%+1.47%+46.05%+65.97%

Financials

2024 2025
Net sales 237M 2.48M 2.15M 2.01M 1.84M 3.46M 3.51M 23.72M 9.26M 118M 9.31M 9.11M 395M 637M 6.67M 5.78M 5.42M 4.94M 9.3M 9.45M 63.81M 24.91M 319M 25.04M 24.5M 1.06B
Net income 7.85M 82.22K 71.27K 66.81K 60.92K 115K 116K 787K 307K 3.93M 309K 302K 13.1M 89.25M 935K 811K 760K 693K 1.3M 1.32M 8.95M 3.49M 44.68M 3.51M 3.43M 149M
Net Debt -57.64M -604K -524K -491K -447K -842K -855K -5.78M -2.26M -28.85M -2.27M -2.22M -96.26M 115M 1.21M 1.05M 982K 896K 1.69M 1.71M 11.57M 4.52M 57.76M 4.54M 4.44M 193M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
26-08-13 87.72 -0.63% 5
26-08-13 ₹88.28 +2.08% 31,400
26-08-12 ₹86.48 -0.43% 51,711
26-08-11 ₹86.85 +6.70% 65,023
26-08-10 ₹81.40 +0.14% 12,531
  1. Stock Market
  2. Stocks
  3. MACINTR Stock